Johnson & Johnson Makes $1 Billion Vaccine Deal

Medical News
>
Critical Care
>
Johnson & Johnson Makes $1 Billion Vaccine Deal

modernClinician Editorial Team Posted August 6th

Company has said it will offer doses at a not-for-profit cost to provide global access to the vaccine

THURSDAY, Aug. 6, 2020 (HealthDay News) — The U.S. government will pay Johnson & Johnson $1 billion for 100 million doses of its vaccine if it is approved by the U.S. Food and Drug Administration, the Washington Post reported Wednesday.

Johnson & Johnson has said it will offer doses at a not-for-profit cost to provide global access to the vaccine. The government can buy 200 million more doses, the Post reported. If the vaccine is approved, the company says it will make more than 1 billion doses through 2021.

“We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use,” Paul Stoffels, M.D., chief scientific officer at Johnson & Johnson, told the Post.

The vaccine has had promising early results. The company is now performing tests on volunteers in the United States and Belgium.

Washington Post Article